drugset / Trial / NCT04690868

A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

NCT04690868 ↗

Phase 1 Completed 43 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-A to AD-2131 in healthy volunteers.

Timeline

Start
2021-10-15
Primary completion
2021-12-11
Completion
2021-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-213-A Unknown — Oral
Subject AD-2131 Unknown — Oral